INTRODUCTION
In Belgium and Japan, frequent occurrence of renal disorders called Chinese herbs nephropathy, the cause of which was discovered to be the presence of aristolochic acids in medicines or health foods made from crude drugs, have been reported. 1, 2) Aristolochic acid I (AA-I) acid II (AA-II) are components from the Aristolochia plants of Aristolochiaceae, and have been also discovered to cause mutagenicity and carcinogenicity.
2) The five herbal medicines originating from the Aristolochia plants, Aristolochia fangchi (root), Aristolochia mandshuriensis (stem), Aristolochia debilis (radix, herb and fruit), Aristolochia contorta (fruit) and Aristolochia contorta (herb), are prescribed in Chinese Pharmacopoeia, and therefore are used in China. In Japan, herbal medicines originating from the Aristolochia plant are not permitted, even as raw materials in pharmaceutical preparations. The herbal medicines used respectively as "Boi" or "Mokutu" in Japan and China are shown in Table 1 . In the Pharmacopoeia of Japan, the herbal medicine called "Boi" is derived from the stem and rhizome of Sinomenium acutum (Sinomenium Stem); "Mokutu" in Japan is derived from the stems of Akebia quinata and Akebia trifoliata (Akebia Stem). Chinese Pharmacopoeia prescribes the root of Stephania tetrandra as "Boi" (Hun-boi); the stem of Sinomenium acutum is called Seihuto, and it is not used for "Boi" in China. The Aristolochia fangchi root is also used as the herbal medicine "Boi," especially in southern China. On the other hand, Akebia Stem is not distributed in the Chinese market because there is no use for it; however, the Aristolochia mandshuriensis stem, Clematis armandii stem and Clematis montana stem are commonly used as "Mokutu." Therefore, the Aristolochia fangchi root and Aristolochia mandshuriensis stem may be substituted for the Japanese herbal medicine Akebia Stem or Sinomenium Stem in Chinese-produced pharmaceutical preparations and health foods. We had a chance to analyze the Kampo medicine formulation, Toki-shigyaku-kagoshuyu-shokyo-to, which caused the renal disorders in 1999. It was doubtful that the Aristolochia mandshuriensis stem was used in the formulation; therefore, we studied detection methods of aristolochic acids by employing HPLC attached with a Photodiode array detector (LC-PDA) and an electric ionization mass spectrometry detector (LC-*To whom correspondence should be addressed: Tokyo Metropolitan Research Laboratory of Public Health, 24-1 Hyakunincho 3-chome Shinjuku-ku, Tokyo 169-0073, Japan. Tel.: +81-3-3363-3231 ex. 3601; Fax.: +81-3-3368-4060; E-mail: tseto@ tokyo-eiken.go.jp EIMS) together with TLC. We also used the LC-PDA to detect AA-I and AA-II in nine other Kampo medicines containing Akebia Stem or Sinomenium Stem.
MATERIALS AND METHODS
Experimental Material ---Chemicals: Aristolochic acid (mixed reagents of AA-I and AA-II) was purchased from EXTRASYNTHESE S. A. (France) and BIOMOL RESEARCH LAB., Inc. (U.S.A.) Herbal medicines Aristolochia fangchi root and Aristolochia mandshuriensis stem were imported from China. The other herbal medicines for Kampo medicine model extracts are standardized articles by the Pharmacopoeia of Japan. Kampo medicine models: the prescribed herbal medicines (Table 2) for one day dose 3) was decocted 4) and double gauze filtered while it was still hot. The filtrate was freeze-dried to form an extract. Kampo medicine positive models contained the Aristolochia plant (Positive model): the Aristolochia fangchi root or the Aristolochia mandshuriensis stem were in place of Japanese crude drug Akebia Stem or Sinomenium, the others used were the same as used in the Kampo medicine models. Equipment ---Freeze-drying machine: Pilot plant freeze-drying machine Genesis 25EL type (BarTis Co., U.S.A.). Photodiode array-HPLC (LC-PDA): 880PU system (JASCO Co., Japan) and PDA detector 996 types (Waters Co., U.S.A). Nuclear magnetic resonance spectrometry (NMR): α-500 type (Japan Electron Optics Laboratory). Mass spectrometry-HPLC (LC-EIMS): Integrity system (Waters Co., U.S.A.) TLC Detection Method ---Sample preparation: a 50% Liquid Chromatography Equipped with a Photodiode Array Detector Detection Method ---Sample preparation: 50 ml of 50% MeOH was added to a 1-0.5 day dose of Kampo medicine extract or formulation, then underwent ultra sonic irradiation for 30 min and next was filtrated (45 µm pore size) to give a sample solution for HPLC analysis. Standard solution: Aristolochic acid (about 5.0 mg) was dissolved in the 50 ml MeOH. The LC-PDA conditions are shown in Table 3 . Liquid Chromatography Equipped with an Electric Ionization Mass Spectrometry Detector Identification ---Sample preparation: The refined sample prepared as well as the TLC sample was suspended with 50% MeOH and loaded on MEGA Bond Elut C18. The aqueous eluent was used as an LC-EIMS sample solution. The LC-EIMS conditions are shown in Table 3 . HPLC Quantitative Analysis ---Sample solution for HPLC: Kampo medicine extract or formulation about 1-0.5 day dose was accurately weighed and 50% MeOH 30 ml was added on it, and underwent ultra sonic irradiation (30 min). After centrifuging (3000 rpm, 5 min) and removal of the solvent, the residue was extracted twice with 50% MeOH (10 ml, 10 min). The supernatants were combined, made up to 50 ml, and filtrated (45 µm pore size) to give a sample solution. Standards: AA-I and AA-II were purified from a commercial mixture by the preparative HPLC, and identified by two-dimensional NMR. The HPLC conditions are shown in Table 3 .
RESULTS AND DISCUSSION

Detection Methods of Aristolochic Acid I and Aristolochic Acid II
A lot of components are present in herbal drug preparations such as Kampo medicines, and they can be observed on the HPLC chromatogram. Only mixtures of AA-I and AA-II are marketed. Trying to confirm elements without pure standards by identifying Rf values of the TLC spots or retention time of HPLC peaks may be misleading. Actually, there are two reports 2, 5) in which AA-I and AA-II peaks of HPLC were reversed on the assignments. Though AA-I and AA-II are both purified by the preparative HPLC, it is desirable to quickly confirm their presence in mixed standard materials. Thus, we carried out TLC, LC-PDA and LC-EIMS analyses on a posi- tive model of Toki-shigyaku-ka-goshuyu-shokyo-to. AA-I and AA-II showed Rf values of 0.51 and 0.48 respectively, and their separation was excellent. However, distinguishing the two was difficult. Under UV 254 nm irradiation both showed up as spots of the same dark color. When sprayed with Dragendorff's reagent, they both were bitter orange brown in color. The spots of AA-I and AA-II were obtained from the positive model of Toki-shigyakuka-goshuyu-shokyo-to. This method was useful as one of the detection methods since it did not require the use of expensive equipment.
The LC-PDA results are shown in Fig. 1 . The UV spectra of the AA-I peak and the AA-II peak are obtained at 14.8 and 11.8 min respectively, and they had the maximum absorptions at 224, 324 and 394 nm and at 215, 252 and 300 nm respectively under the examined conditions. In literature, the maximum absorptions of the AA-I 6) in ethanol solution were found to be 221 nm (log ε 4.47), 250 (4.51), 317 (4.05) and 388 (3.78); and for AA-II7, 7) they were 249 nm (log ε 4.58), 296 (4.12) and 362 (3.59). These disagreements were thought to arise according to a difference of the matrix. Since AA-I and AA-II were respectively identified by not only the retention times but also by the spectra from the positive model of Toki-shigyaku-ka-goshuyu-shokyo-to, this method also proved to be effective. Absences of AA-I and AA-II peaks were confirmed in the Kampo medicine model of Toki-shigyaku-ka-goshuyushokyo-to. As a result of the additional examination of the Kampo medicine model, the detection limit was 80 ppm. The MS spectrum of LC-EIMS peaks of AA-I and AA-II gave molecular ion peaks, m/z 341 and m/z 311 respectively, and fragment peaks that formed by the elimination of the nitro group, m/z 295 and m/z 265, as base peaks, as shown in Fig. 2 . These MS data, including the other fragments, agreed with a literature description. 7) Usually acetic acid was added to the HPLC mobile phase in order to control ionization of testing materials. However, it was found that the MS spectrum had changed greatly, making it difficult to compare it with literature data by use of acetic acid in the HPLC mobile phase. Therefore, although the addition of acetic acid improved the separation of the peaks, it was not used in this case. For the ion source protection, a positive model of Toki-shigyaku-ka-goshuyu-shokyo-to was analyzed after refinement by the liquid-liquid distribution method and then with an ODS cartridge. As a result, the HPLC peaks and the MS spectrum that corresponded to AA-I and AA-II could be detected from the positive model of Toki-shigyaku-ka-goshuyushokyo-to. LC-EIMS was useful for quick identification even when pure standards could not be ob-tained. LC-EIMS is a comparatively new technique owing to EI of the ionization mode, and it enabled us to refer to the abundant MS spectrum data that had been described in literature or saved in libraries.
